Perceived changes in mental health and social engagement attributed to a single psychedelic experience in autistic adults: results from an online survey

Allison C, Auyeung B, Baron-Cohen S (2012) Toward brief “red flags” for autism screening: The short autism spectrum quotient and the short quantitative checklist in 1,000 cases and 3,000 controls. J Am Acad Child Adolesc Psychiatry 51(2):202–212

Article  PubMed  Google Scholar 

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Author, Arlington, VA

Book  Google Scholar 

Andersen KA, Carhart-Harris R, Nutt DJ, Erritzoe D (2021) Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies. Acta Psychiatr Scand 143(2):101–118

Article  PubMed  Google Scholar 

Ashwood KL, Gillan N, Horder J, Hayward H, Woodhouse E, McEwen FS ... Murphy DG (2016) Predicting the diagnosis of autism in adults using the Autism-Spectrum Quotient (AQ) questionnaire. Psychol Med 46(12):2595–2604

Ayub R, Sun KL, Flores RE, Lam VT, Jo B, Saggar M, Fung LK (2021) Thalamocortical connectivity is associated with autism symptoms in high-functioning adults with autism and typically developing adults. Transl Psychiatry 11(1):93

Article  PubMed  PubMed Central  Google Scholar 

Barber G, Nemeroff CB, Siegel S (2022) A case of prolonged mania, psychosis, and severe depression after psilocybin use: implications of increased psychedelic drug availability. Am J Psychiatry 179(12):892–896

Article  PubMed  Google Scholar 

Barrett FS, Johnson MW, Griffiths RR (2015) Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. J Psychopharmacol 29(11):1182–1190

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barrett FS, Bradstreet MP, Leoutsakos JMS, Johnson MW, Griffiths RR (2016) The challenging experience questionnaire: characterization of challenging experiences with psilocybin mushrooms. J Psychopharmacol 30(12):1279–1295

Article  PubMed  PubMed Central  Google Scholar 

Beidel DC, Rao PA, Scharfstein L, Wong N, Alfano CA (2010) Social skills and social phobia: An investigation of DSM-IV subtypes. Behav Res Ther 48(10):992–1001

Article  PubMed  PubMed Central  Google Scholar 

Bird G, Cook R (2013) Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism. Transl Psychiatry 3(7):e285–e285

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blond BN, Schindler EA (2023) Case report: psychedelic-induced seizures captured by intracranial electrocorticography. Front Neurol 14:1214969

Article  PubMed  PubMed Central  Google Scholar 

Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK ... Zettle RD (2011) Preliminary psychometric properties of the Acceptance and Action Questionnaire–II: A revised measure of psychological inflexibility and experiential avoidance. Behavior Ther 42(4):676–688

Brouwer A, Carhart-Harris RL (2021) Pivotal mental states. J Psychopharmacol 35(4):319–352

Article  PubMed  Google Scholar 

Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR (2016) Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences. J Psychopharmacol 30(12):1268–1278

Article  PubMed  PubMed Central  Google Scholar 

Carbonaro TM, Johnson MW, Griffiths RR (2020) Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan. Psychopharmacology 237(8):2293–2304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris RL, Friston KJ (2019) REBUS and the anarchic brain: toward a unified model of the brain action of psychedelics. Pharmacol Rev 71(3):316–344

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris RL, Goodwin GM (2017) The therapeutic potential of psychedelic drugs: past, present, and future. Neuropsychopharmacology 42(11):2105–2113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris RL, Nutt DJ (2017) Serotonin and brain function: a tale of two receptors. J Psychopharmacol 31(9):1091–1120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carhart-Harris RL, Erritzoe D, Haijen ECHM, Kaelen M, Watts R (2018a) Psychedelics and connectedness. Psychopharmacology 235(2):547–550

Article  CAS  PubMed  Google Scholar 

Carhart-Harris RL, Roseman L, Haijen E, Erritzoe D, Watts R, Branchi I, Kaelen M (2018b) Psychedelics and the essential importance of context. J Psychopharmacol 32(7):725–731

Article  PubMed  Google Scholar 

Chang YC, Quan J, Wood JJ (2012) Effects of anxiety disorder severity on social functioning in children with autism spectrum disorders. J Dev Phys Disabil 24:235–245

Article  Google Scholar 

Chiang HL, Gau SSF (2016) Comorbid psychiatric conditions as mediators to predict later social adjustment in youths with autism spectrum disorder. J Child Psychol Psychiatry 57(1):103–111

Article  PubMed  Google Scholar 

Close JB, Hajien EC, Watts R, Roseman L, Carhart-Harris RL (2020) Psychedelics and psychological flexibility–Results of a prospective web-survey using the Acceptance and Action Questionnaire II. J Contextual Behav Sci 16(37):44

Google Scholar 

Connor KM, Davidson JR, Churchill LE, Sherwood A, Weisler RH, Foa E (2000) Psychometric properties of the Social Phobia Inventory (SPIN): New self-rating scale. Br J Psychiatry 176(4):379–386

Article  CAS  PubMed  Google Scholar 

Conway JR, Catmur C, Bird G (2019) Understanding individual differences in theory of mind via representation of minds, not mental states. Psychon Bull Rev 26:798–812

Article  PubMed  PubMed Central  Google Scholar 

Cook J, Hull L, Crane L, Mandy W (2021) Camouflaging in autism: A systematic review. Clin Psychol Rev 89:102080

Article  PubMed  Google Scholar 

Coughlin SS (1990) Recall bias in epidemiologic studies. J Clin Epidemiol 43(1):87–91

Article  CAS  PubMed  Google Scholar 

Danforth A (2021) Psychedelic-Assisted Therapy for Social Adaptability in Autistic Adults. Disruptive Psychopharmacology. Springer International Publishing, Cham, pp 71–92

Chapter  Google Scholar 

Danforth AL, Grob CS, Struble C, Feduccia AA, Walker N, Jerome L ... and Emerson A (2018) Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235(11):3137–3148

Davis AK, Barrett FS, Griffiths RR (2020) Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. J Contextual Behav Sci 15:39–45

Article  PubMed  Google Scholar 

Ee D, Hwang YI, Reppermund S, Srasuebkul P, Trollor JN, Foley KR, Arnold SR (2019) Loneliness in adults on the autism spectrum. Autism in Adulthood 1(3):182–193

Article  PubMed  PubMed Central  Google Scholar 

Fliss R, Le Gall D, Etcharry-Bouyx F, Chauviré V, Desgranges B, Allain P (2016) Theory of Mind and social reserve: Alternative hypothesis of progressive Theory of Mind decay during different stages of Alzheimer’s disease. Soc Neurosci 11(4):409–423

Article  PubMed  Google Scholar 

Forstmann M, Yudkin DA, Prosser AM, Heller SM, Crockett MJ (2020) Transformative experience and social connectedness mediate the mood-enhancing effects of psychedelic use in naturalistic settings. Proc Natl Acad Sci 117(5):2338–2346

Article  CAS  PubMed  PubMed Central  Google Scholar 

Freidel N, Kreuder L, Rabinovitch BS, Chen FY, Huang RS, Lewis EC (2024) Psychedelics, epilepsy, and seizures: a review. Front Pharmacol 14:1326815

Article  PubMed  PubMed Central  Google Scholar 

Garcia-Romeu A, Barrett FS, Carbonaro TM, Johnson MW, Griffiths RR (2021) Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches. J Psychopharmacol 35(4):353–361

Article  CAS  PubMed  PubMed Central 

Comments (0)

No login
gif